Vitae Pharmaceuticals (VTAE) Ends 3Q With Cash Available Through 2016; Piper Jaffray Raises Price Target to $18

Go back to Vitae Pharmaceuticals (VTAE) Ends 3Q With Cash Available Through 2016; Piper Jaffray Raises Price Target to $18
(NASDAQ: VTAE) Delayed: 21.00 --0 (-0%)
Previous Close $21.00    52 Week High $21.04 
Open $1.67    52 Week Low $4.08 
Day High $21.00    P/E N/A 
Day Low $21.00    EPS $0.00 
Volume 192,326